Results: Pancreatic Cancer

Results from Abstracts

Pick one of the followings

*Some genes may be words of complete meaning. In any case, if present, they are relevant key words.

Legend:

***	p-value <= 0.001
**	p-value <= 0.01
*	p-value <= 0.05
n.s.	not significant

Top Ranked Genes, Molecules or Short Names*

Gem ***
Pc ***
Kras ***
Hr ***
Cck **
Mia **
Adam8 *
Nr1d2 *
Acd *
Dst *
Tff2 *
Csf2 *
Aplp2 *
Ndrg1 *
Oas1 *
Phgdh *
Stat3 *
Socs5 *
Dclk1 *
Cldn1 *
Smo *
Oas3 *
Epha2 *
Prmt5 *
Tgfbr1 *
Sufu *
Loxl2 *
Pvr n.s.
Map4k4 n.s.
Ccl20 n.s.
Fezf1 n.s.
Cdkn2a n.s.
She n.s.
Adam9 n.s.
Bag3 n.s.
S100a6 n.s.
Rel n.s.
Eif4e n.s.
Cd44 n.s.
Ptgs2 n.s.
S100a9 n.s.
B2m n.s.
Ywhaz n.s.
Comp n.s.
Cd86 n.s.
Dancr n.s.
Hif1a n.s.
Cxcr2 n.s.
Stk11 n.s.
Chek2 n.s.
Shh n.s.
Bcl2l1 n.s.
Runx2 n.s.
Per1 n.s.
Cdkn2b n.s.
Aip n.s.
Cd80 n.s.
Egfr n.s.
Apc n.s.
Has2 n.s.
Aes n.s.
Met n.s.
Src n.s.
Cxcl1 n.s.
S100a4 n.s.
Hgf n.s.
Adm n.s.
Pdx1 n.s.
Ptch1 n.s.
Ugt1a1 n.s.
C7 n.s.
Zeb1 n.s.
Foxm1 n.s.
Mmp2 n.s.
Rnf43 n.s.
Mmp14 n.s.
Taz n.s.
Bax n.s.
Malat1 n.s.
Cd40 n.s.
Igf1 n.s.
Axl n.s.
Palb2 n.s.
Tp53 n.s.
Mdm2 n.s.
Cd24 n.s.
Rhoc n.s.
Il3 n.s.
Tnc n.s.
Atf4 n.s.
Hmga2 n.s.
Ppp2r2a n.s.
Vim n.s.
Nsd1 n.s.
Setd2 n.s.
Cxcl16 n.s.
Slc16a4 n.s.
Ca9 n.s.
Cdk6 n.s.
Ckb n.s.

Top Ranked Key Phrases

Pancreatic ductal adenocarcinoma pdac remains ***
Human pancreatic cancer cell lines ***
Locally advanced pancreatic cancer lapc ***
Pancreatic ductal adenocarcinoma pdac ***
Pancreatic ductal adenocarcinoma pda ***
Epithelial mesenchymal transition emt ***
Cancer genome atlas tcga ***
Pancreatic cancer cell lines ***
Locally advanced pancreatic cancer ***
Cancer stem cells cscs ***
Pancreatic stellate cells pscs ***
Human pancreatic cancer cells ***
Borderline resectable pancreatic cancer ***
Differentially expressed genes degs ***
Progression free survival pfs ***
Disease free survival dfs ***
Pancreatic ductal adenocarcinoma ***
Epithelial mesenchymal transition ***
Luciferase reporter assay ***
Kaplan meier method ***
Long term survival ***
Cell cycle arrest **
Pc cell lines **
Mesenchymal transition emt **
Long term outcomes **
Pdac cell lines **
Cd8 t cells **
Superior mesenteric artery **
Tumor bearing mice **
Pancreatic cancer remains **
Human pancreatic cancer **
Advanced pancreatic cancer **
Dose dependent manner **
Lymph node metastasis **
Unresectable pancreatic cancer **
Pancreatic cancer tissue **
Independent prognostic factor **
Resectable pancreatic cancer **
Metastatic pancreatic cancer **
Including pancreatic cancer **
Disease free survival **
Pancreatic cancer pc **
Pancreatic cancer cells **
Progression free survival **
Overall survival os **
Western blot analysis **
Pancreatic cancer therapy **
Mia paca 2 cells **
Pancreatic cancer tissues **
Colony formation assay **
Pd l1 expression **
Anti tumor effects **
Cancer related deaths **
5 year survival rate **
Year survival rate **
Cancer related death **
Pancreatic cancer risk **
Median overall survival **
95% confidence intervals cis **
Independent prognostic factors **
Pancreatic cancer progression **
Pancreatic cancer treatment *
Potential therapeutic target *
Extremely poor prognosis *
Pancreatic cancer patients *
Underlying molecular mechanisms *
Second leading cause *
Fourth leading cause *
95% confidence interval ci *
Cell lines *
Locally advanced *
Hazard ratio *
Pancreatic adenocarcinoma n.s.
Nf Κb n.s.
Portal vein n.s.
Cell cycle n.s.
Odds ratio n.s.
Cell growth n.s.
Nab ptx n.s.
Signaling pathways n.s.
Pancreatic carcinoma n.s.
Tumor suppressor n.s.
Nab paclitaxel n.s.
Mouse model n.s.
Multivariable analysis n.s.
Pd l1 n.s.
Borderline resectable n.s.
Pancreatic body n.s.
Mouse models n.s.
Present study aimed n.s.
Adjacent tissues n.s.
Dna replication n.s.
Nk cells n.s.
Tumor tissue n.s.

Top Ranked Mesh Terms

Aged 80 and over ***
Middle aged ***
Prognosis ***
Aged ***
Humans ***
Apoptosis ***
Gene expression regulation neoplastic ***
Female ***
Pathology ***
Pancreatic neoplasms ***
Carcinoma pancreatic ductal ***
Male ***
Cell proliferation ***
Drug therapy ***
Adenocarcinoma ***
Cell line tumor ***
Retrospective studies ***
Treatment outcome ***
Deoxycytidine ***
Biomarkers tumor **
Antineoplastic agents **
Signal transduction **
Mortality **
Mice nude **
Xenograft model antitumor assays **
Mice **
Antineoplastic combined chemotherapy protocols **
Pancreas **
Methods **
Adult **
Pancreatectomy **
Disease progression **
Genetics **
Neoadjuvant therapy **
Risk factors **
Tumor microenvironment **
Survival rate **
Cell movement **
Diagnosis **
Neoplasm staging **
Metabolism **
Micrornas *
Disease-free survival *
Survival analysis *
Neoplasm invasiveness *
Neoplasm metastasis *
Pancreaticoduodenectomy *
Drug combinations *
Drug resistance neoplasm *
Cell survival *
Rad51 recombinase *
Retroperitoneal neoplasms *
Carcinogenesis *
Up-regulation *
Albumins *
Small molecule libraries *
Molecular imaging *
Tumor escape *
Mice inbred balb c *
Paclitaxel *
Multimodal imaging *
Drug-related side effects and adverse reactions *
Cancer pain *
Pancreatic stellate cells *
Clinical decision-making *
Leucovorin *
Glutaminase *
Case-control studies *
G2 phase cell cycle checkpoints *
Embolization therapeutic *
Cell plasticity *
Venous thromboembolism *
Thromboplastin *
Immunoconjugates *
B7 antigens *
Extracellular signal-regulated map kinases *
Unfolded protein response *
Diagnostic imaging *
Bile duct neoplasms *
Digestive system neoplasms *
Cyclin-dependent kinase inhibitor p27 *
Endosonography *
Mistletoe *
Vimentin *
Oxonic acid *
Tegafur *
Digestive system surgical procedures *
Neuroendocrine tumors *
Saponins *
Genetic predisposition to disease *
A549 cells *
Pharmacology *
Pancreatitis chronic *
Microsatellite instability *
Neoplasm recurrence local *
Cell self renewal *
Constriction pathologic *
Receptor notch1 *
Ribonucleotide reductases *
Nutritional support *

Results for: Pancreatic Cancer

Results from Abstracts

KEGG Pathways

Gene Ontology Biological Processes